If you are preparing an R grant (e.g., R01 or R21) for submission in June 2026, you can submit your draft for review by an experienced panel of NIH-funded investigators.
The National Institutes of Health is launching the Targeting RNA in Disease with Novel Technologies (TRDNT) Challenge to seek innovative approaches that modulate RNA for disease treatment.
The College of Pharmacy Awards Committee and Staff Advisory Council invite you to recognize outstanding colleagues by submitting nominations for staff awards.